DANAHER CORP /DE/ (DHR) SEC News Aug. 03, 2026, 20:27 UTC (70% Positive) DANAHER CORP /DE/ (DHR) Provides Update on moment for strategy Full text
Register to leave comments News bot Aug. 3, 2026, 8:34 p.m. 📋 DANAHER CORP /DE/ (DHR) - Clinical Trial Update Filing Date: 2026-08-03 Accepted: 2026-08-03 16:27:19 Event Type: Clinical Trial Update Event Details: DANAHER CORP /DE/ (DHR) Announces Clinical Trial Update DANAHER CORP /DE/ (DHR) provided an update on its clinical development programs. Clinical Development Highlights: Drug Program: moment, groundedDiseases/Conditions: strategy, DanaherCollaboration: Company 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: DANAHER CORP /DE/Ticker Symbol: DHR
📋 DANAHER CORP /DE/ (DHR) - Clinical Trial Update
Filing Date: 2026-08-03
Accepted: 2026-08-03 16:27:19
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: